Prof. Dr. Oliver Germershaus

    Tätigkeiten an der FHNW

    Leiter Institut für Pharmatechnologie und Biotechnologie

    Lehre

    Bachelor
    Reinraumtechnologie und Laborarbeit; Modulleitung
    Parenteralia und Biologische Wirkstoffe; Modulleitung
    Verpackung und Logistik

    Master
    Drug Formulation and Delivery: Macromolecular Drugs
    Drug Manufacturing: Advanced Pharmaceutical Production Units
    Applied Bioanalytics: Analytical Assessment of Biologic Drugs

    Betreuung von Studierendenprojekten, Bachelor- und Masterarbeiten

    Forschung

    laden

    Profil

    Oliver Germershaus is a professor for pharmaceutical technology of macromolecular drugs at the University of Applied Arts and Sciences Northwestern Switzerland (FHNW) since 2014. His research focusses on development of drug delivery systems for large molecules (peptides, proteins, and nucleic acids), formulation and process development for biologic drugs and the investigation of drug/excipient and drug/packaging interactions. 

    Prior to joining FHNW, Oliver Germershaus was an assistant professor for pharmaceutics and biopharmacy at the University of Wuerzburg, Germany from 2011 until 2014 and held scientist positions of increasing responsibility at the Department for Pharmaceutical Research and Development at Novartis Pharma, Basel, Switzerland from 2007 until 2011. 

    Oliver Germershaus graduated from University of Marburg, Germany in 2002 and is licensed as a pharmacist in Germany. He obtained a Master degree in pharmacy (Diplompharmazeut) from the University of Halle-Wittenberg, Germany in 2003 and performed his PhD studies in the group of Prof. Thomas Kissel at the University of Marburg, Germany from 2004 until 2007.

    Member of:

    • Swiss Academy of Pharmaceutical Sciences (SAPhW)
      Board Member, Co-Organizer PharmaLunch Basel 
    • Controlled Release Society German Chapter (CRS Germany) 
      Vice President 2014/2015, President 2015/2016
    • Biotechnet Switzerland
      Leader Biologics Platform 
    • Swiss Society of Industrial Pharmacists (GSIA)
    • German Pharmaceutical Society (DPhG)
    • Controlled Release Society (CRS)
    • Parenteral Drug Association (PDA)
    • American Chemical Society (ACS)

    Editorial Board Member:

    • Asian Journal of Pharmaceutical Sciences

    Reviewer:

    • German Research Foundation (DFG) 

      • Journal of Controlled Release, Biomaterials, European Journal of Pharmaceutics and Biopharmaceutics, Acta Biomaterialia, International Journal of Pharmaceutics, European Journal of Pharmaceutical Sciences, Biotechnology Progress, Biotechnology Journal, Journal of Materials Chemistry, Colloids and Surfaces B. Biointerphases
  • Institut für Pharmatechnologie und Biotechnologie

    Fachhochschule Nordwestschweiz FHNW
    Hochschule für Life Sciences
    Institut für Pharmatechnologie und Biotechnologie

    Hofackerstrasse 30

    4132 Muttenz